We are excited to announce the release of the National Centre for Asbestos Related Diseases (NCARD) 2023 Annual Report. This document showcases our team’s remarkable achievements and unwavering efforts in addressing asbestos-related diseases over the past year.

2023 marked a significant transition for NCARD, with new leadership at the helm and a renewed focus on our core mission. Despite these changes, our commitment to research and improving patient outcomes remained steadfast.

Within these pages, you will find detailed accounts of our research breakthroughs, clinical advancements, and community engagement initiatives. From our pioneering work with the Western Australia National Imaging Facility Node (WA NIF) to the continued success of our PhD students, this report reflects the breadth and depth of NCARD’s impact.

We are particularly proud of our researchers’ numerous awards and grants, which underscore the quality and importance of our work. These accolades recognise individual achievements and highlight NCARD’s position at the forefront of asbestos-related disease research.

As we look to the future, we remain dedicated to our vision of leading scientific advancement and discovery to improve the lives of those affected by asbestos-related diseases. We invite you to explore this report and join us in our ongoing mission to reduce the impact of asbestos-related diseases and improve outcomes for those affected.

Thank you for your continued support and interest in NCARD’s vital work.

2023 Annual Report